MedPath

The effect of reminiscence therapy

Phase 3
Conditions
Cognitive disorders and depression in hemodialysis' patients.
Dementia in other specified diseases classified elsewhere
Registration Number
IRCT201607186318N8
Lead Sponsor
Vice Chancellor for research of Semnan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
10
Inclusion Criteria

age 25 to 75 years; ability to read; write; visual and verbal communication; lack of cognitive or chronic mental disorders; no deaths of a close family and friends in the last three months; lack of addiction to drugs abuse or alcohol; get MMSE questionnaire score 25-10. Exclusion criteria: having a history of suicidal thoughts; psychosis; mental retardation; vision and hearing problems; absence more than one session.

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Cognitive status. Timepoint: Before, immediately after and one month after the intervention. Method of measurement: Variable measurement method: In this study, Cognitive status is measured by using MMSE questionnaire. Score of cognitive health (25-30), mild cognitive disorders (21-24), moderate (10-20) severe (<9). Information for each person will be recorded in a specific questionnaire for each patient.
Secondary Outcome Measures
NameTimeMethod
Depression. Timepoint: Before, immediately after and one month after the intervention. Method of measurement: Depression is measured by using the Beck Depression Inventory. Beck Depression Inventory tests their polls. There are a total of 21 tests of four-point scale from zero to three to respond. Scores range from zero to 63. Score and severity of depression is divided to mild (11-16), moderate (17-29) and major (30-63). Information for each person will be recorded in a specific questionnaire for each patient.
© Copyright 2025. All Rights Reserved by MedPath